The U.S. Patent Office’s program for expedited examination of design applications under 37 CFR 1.155 (often called the design “rocket docket”), which was suspended earlier this year, was formally canceled…
Knobbe Martens attorneys Mark Lezama and Lincoln Essig, along with Sam Olive, Senior Director and Associate General Counsel, Intellectual Property at Cisco, hosted a webinar with ACC Southern California on…
IRVINE, Calif., August 21, 2025 – Knobbe Martens is pleased to share that dozens of the firm’s partners, representing a range of practice areas and offices across the country, have…
SAN DIEGO, August 20, 2025 – A Knobbe Martens team served as intellectual property and government contract counsel to General Atomics Aeronautical Systems, Inc. in its acquisition of the assets…
SAN DIEGO, August 19, 2025 – Knobbe Martens partners Joe Reisman and Ryan Melnick serve as IP counsel to Ligand Pharmaceuticals Incorporated, a biopharmaceutical royalty aggregator. Dr. Reisman and Dr….
In the AdAge article “How Brands Can Avoid Risk When Bidding on Competitor Trademarks as Search Keywords,” lawyers Jonathan Menkes and Zachary Greenberg explore the complex legal landscape of digital…
IRVINE, Calif., August 14, 2025 – Knobbe Martens is pleased to share that a number of the firm’s partners have been recognized in the 2025 edition of the IAM Strategy…
IRVINE, Calif., August 14, 2025 – Knobbe Martens is pleased to share that partners Andrea Cheek, Kendall Loebbaka, and Adam Powell have been named to Benchmark Litigation’s 2025 “40 &…
Combination Dosing Regimen Not Obvious Despite Overlapping Prior-Art Ranges Justin J. Gillett & Alex Martin del Campo JANSSEN PHARMACEUTICALS, INC. v. TEVA PHARMACEUTICALS USA, INC. Before Prost, Reyna, and Taranto….
Space Technology Investments Clear the Launch Tower in 2025 Tom Cowan Investments in space technology are off to a strong start in the first half of 2025. The rising trend…
